Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc.

NASDAQ:HRTX

Overview | Financials
Company Name Heron Therapeutics, Inc.
Symbol HRTX
Currency USD
Price 1.75
Market Cap 265,419,000
Dividend Yield 0%
52-week-range 0.53 - 3.93
Industry Biotechnology
Sector Healthcare
CEO Mr. Craig Alexander Collard
Website https://www.herontx.com

An error occurred while fetching data.

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It

Related Stocks

HilleVax, Inc. logo

HilleVax, Inc.

HLVX

1.91 USD

Absci Corporation logo

Absci Corporation

ABSI

4.07 USD

ALX Oncology Holdings Inc. logo

ALX Oncology Holdings Inc.

ALXO

1.45 USD

BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc.

BTAI

0.68 USD

Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc.

FULC

3.49 USD

C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc.

CCCC

6.06 USD

Athira Pharma, Inc. logo

Athira Pharma, Inc.

ATHA

0.66 USD

OraSure Technologies, Inc. logo

OraSure Technologies, Inc.

OSUR

4.29 USD

EyePoint Pharmaceuticals, Inc. logo

EyePoint Pharmaceuticals, Inc.

EYPT

11.63 USD

Financials

Numbers are in millions USD

Numbers are in millions USD